Prostaglandin F2α negatively regulates bone resorption in murine osteoclast development

Prostaglandins and Other Lipid Mediators

Volumn 87, Issue 1-4, 2008, Pages 26-33

  Kamon, M ^a   Fujita, D ^a   Goto, N ^a   Amano, H ^b   Sakamoto, K ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

Bone metabolism; Bone resorption; FP; Osteoclast; Prostaglandin

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITONIN RECEPTOR; CATHEPSIN K; FLUPROSTENOL; GELATINASE B; OSTEOCLAST DIFFERENTIATION FACTOR; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; TRANSCRIPTION FACTOR NFAT; PROSTAGLANDIN F2ALPHA RECEPTOR; PROSTAGLANDIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ASSAY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; MOUSE; MYELOMA CELL; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL LINE; CELL NUCLEUS; CYTOLOGY; DRUG EFFECT; METABOLISM;

ANIMALS; BONE MARROW CELLS; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; DINOPROST; MICE; OSTEOCLASTS; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION;

EID: 55549120523     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2008.06.002     Document Type: Article

References (49)

1. Saika M., Inoue D., Kido S., and Matsumoto T. 17 beta-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha. Endocrinology 142 (2001) 2205-2212
2. Jimi E., Nakamura I., Amano H., et al. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology 137 (1996) 2187-2190
3. Takahashi N., Akatsu T., Udagawa N., et al. Osteoblastic cells are involved in osteoclast formation. Endocrinology 123 (1988) 2600-2602
4. Yasuda H., Shima N., Nakagawa N., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95 (1998) 3597-3602
5. Lacey D.L., Timms E., Tan H.L., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (1998) 165-176
6. Suda T., Nakamura I., Jimi E., and Takahashi N. Regulation of osteoclast function. J Bone Miner Res 12 (1997) 869-879
7. Amano H., Yamada S., and Felix R. Colony-stimulating factor-1 stimulates the fusion process in osteoclasts. J Bone Miner Res 13 (1998) 846-853
8. Yoshida H., Hayashi S., Kunisada T., et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345 (1990) 442-444
9. Tanaka S., Takahashi N., Udagawa N., et al. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 91 (1993) 257-263
10. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., and Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20 (1999) 345-357
11. Fujita D., Yamashita N., Iita S., Amano H., Yamada S., and Sakamoto K. Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells. Prostaglandins Leukot Essen Fatty Acids 68 (2003) 351-358
12. Kobayashi Y., Mizoguchi T., Take I., Kurihara S., Udagawa N., and Takahashi N. Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1. J Biol Chem 280 (2005) 11395-11403
13. Tsuboi K., Sugimoto Y., and Ichikawa A. Prostanoid receptor subtypes. Prostaglandins Other Lipid Mediat 68/69 (2002) 535-556
14. Kobayashi Y., Take I., Yamashita T., et al. Prostaglandin E2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors. J Biol Chem 280 (2005) 24035-24042
15. Tsujisawa T., Inoue H., and Nishihara T. SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL. J Bone Miner Res 20 (2005) 15-22
16. Chambers T.J., and Ali N.N. Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6-oxo-E1. J Pathol 139 (1983) 383-397
17. Fuller K., and Chambers T.J. Effect of arachidonic acid metabolites on bone resorption by isolated rat osteoclasts. J Bone Miner Res 4 (1989) 209-215
18. Dietrich J.W., Goodson J.M., and Raisz L.G. Stimulation of bone resorption by various prostaglandins in organ culture. Prostaglandins 10 (1975) 231-240
19. 2 production. Endocrinology 126 (1990) 1076-1079
20. Tokuda H., Oiso Y., and Kozawa O. Protein kinase C activation amplifies prostaglandin F2 alpha-induced prostaglandin E2 synthesis in osteoblast-like cells. J Cell Biochem 48 (1992) 262-268
21. Sugimoto Y., Hasumoto K., Namba T., et al. Cloning and expression of a cDNA for mouse prostaglandin F receptor. J Biol Chem 269 (1994) 1356-1360
22. Ito S., Sakamoto K., Mochizuki-Oda N., et al. Prostaglandin F2 alpha receptor is coupled to Gq in cDNA-transfected Chinese hamster ovary cells. Biochem Biophys Res Commun 200 (1994) 756-762
23. Davis J.S., Weakland L.L., Weiland D.A., Farese R.V., and West L.A. Prostaglandin F2 alpha stimulates phosphatidylinositol 4,5-bisphosphate hydrolysis and mobilizes intracellular Ca2+ in bovine luteal cells. Proc Natl Acad Sci USA 84 (1987) 3728-3732
24. Takayanagi H., Kim S., Koga T., et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3 (2002) 889-901
25. Matsuo K., Galson D.L., Zhao C., et al. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem 279 (2004) 26475-26480
26. Lee S.W., Kwak H.B., Chung W.J., Cheong H., Kim H.H., and Lee Z.H. Participation of protein kinase C beta in osteoclast differentiation and function. Bone 32 (2003) 217-227
27. Wang C., Steer J.H., Joyce D.A., Yip K.H., Zheng M.H., and Xu J. 12-O-Tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation. J Bone Miner Res 18 (2003) 2159-2168
28. Meiyanto E., Hoshijima M., Ogawa T., Ishida N., and Takeya T. Osteoclast differentiation factor modulates cell cycle machinery and causes a delay in s phase progression in RAW264 cells. Biochem Biophys Res Commun 282 (2001) 278-283
29. Ishida N., Hayashi K., Hoshijima M., et al. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 277 (2002) 41147-41156
30. Ly I.A., and Mishell R.I. Separation of mouse spleen cells by passage through columns of sephadex G-10. J Immunol Methods 5 (1974) 239-247
31. Niida S., Kaku M., and Amano H. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in support of osteoclastic bone resorption. J Exp Med 190 (1999) 293-298
32. Tanio Y., Yamazaki H., Kunisada T., et al. CD9 molecule expressed on stromal cells is involved in osteoclastgenesis. Exp Hematol 27 (1999) 853-859
33. Matsumoto M., Sudo T., Maruyama M., Osada H., and Tsujimoto M. Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor. FEBS Lett 486 (2000) 23-28
34. Palokangas H., Mulari M., and Vaananen H.K. Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts. J Cell Sci 110 (1997) 1767-1780
35. Henriksen K., Gram J., Schaller S., et al. Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II. Am J Pathol 164 (2004) 1537-1545
36. Abramoff M.D., Magelhaes P.J., and Ram S.J. Image processing with image. J Biophoton Int 11 (2004) 36-42
37. Yanai H. Statcel-the useful add-in software forms on Excel. 2nd ed. (2004), OMS, Saitama, Japan
38. Miyamoto T., and Suda T. Differentiation and function of osteoclasts. Keio J Med 52 (2003) 1-7
39. Yagi M., Miyamoto T., Sawatani Y., et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 202 (2005) 345-351
40. Ralph P., and Nakoinz I. Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS. J Immunol 119 (1977) 950-954
41. Newton A.C. Protein kinase C: structure, function, and regulation. J Biol Chem 270 (1995) 28495-28498
42. Hirotani H., Tuohy N.A., Woo J.T., Stern P.H., and Clipstone N.A. The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem 279 (2004) 13984-13992
43. Su Y., Chakraborty M., Nathanson M.H., and Barrton R. Differential effects of the 3′, 5′-cyclic adenosine monophosphate and protein kinase C pathway on the response of isolated rat osteoclasts to calcitonin. Endocrinology 131 (1992) 1497-1502
44. Takahashi N., Akatsu T., Sasaki T., et al. Induction of calcitonin receptors by 1 alpha, 25-dihydroxyvitamin D3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells. Endocrinology 123 (1988) 1504-1510
45. Wada S., Udagawa N., Akatsu T., Nagata N., Martin T.J., and Findlay D.M. Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts. Endocrinology 138 (1997) 521-529
46. Miyamoto K., Nishioka T., Waki Y., et al. Phosphodiesterase 4 inhibitor rolipram potentiates the inhibitory effect of calcitonin on osteoclastogenesis. J Bone Miner Metab 24 (2006) 260-265
47. Insogna K.L., Sahni M., Grey A.B., et al. Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts. J Clin Invest 100 (1997) 2476-2485
48. Weitzmann M.N., Cenci S., Rifas L., Haug J., Dipersio J., and Pacifici R. T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms. J Bone Miner Res 16 (2001) 328-337
49. Kanematsu M., Sato T., Takai H., Watanabe K., Ikeda K., and Yamada Y. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. J Bone Miner Res 15 (2000) 1321-1329